Donor fecal microbiota transplant effective for C. difficile infection

August 24, 2016

(HealthDay)—For patients with recurrent Clostridium difficile infection (CDI), donor fecal microbiota transplantation (FMT) is safe and more efficacious than autologous FMT, according to a study published online Aug. 23 in the Annals of Internal Medicine.

In an effort to examine the efficacy and safety of FMT, Colleen R. Kelly, M.D., from the Warren Alpert Medical School of Brown University in Providence, R.I., and colleagues conducted a involving 46 patients at two with three or more recurrences of CDI. Patients were randomized to FMT with donor stool or patient's own stool administered by colonoscopy.

In intention-to-treat analysis, the researchers found that 90.9 percent of patients in the donor FMT group achieved clinical cure, compared with 62.5 percent in the autologous FMT group (P = 0.042). There was variation by site in resolution after autologous FMT (nine of 10 versus six of 14; P = 0.033). For the nine who developed recurrent CDI after autologous FMT, there were no further episodes of CDI after subsequent donor FMT. No FMT-related serious adverse events were observed. Gut bacterial community diversity and composition were restored by donor FMT to resemble that of healthy donors.

"Donor stool administered via colonoscopy seemed safe and was more efficacious than autologous FMT in preventing further CDI episodes," the authors write.

Explore further: Frozen vs. fresh fecal transplantation for C. diff. infection shows similar effectiveness

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Frozen vs. fresh fecal transplantation for C. diff. infection shows similar effectiveness

January 12, 2016
Among adults with Clostridium difficile infection that is recurrent or not responsive to treatment, the use of frozen compared with fresh fecal microbiota transplantation (FMT) did not result in a significantly lower rate ...

FMT now available in capsule form: could this be the end of antibiotics in C. difficile?

October 6, 2015
A new capsule form of faecal microbiota transplantation (FMT) has raised hopes that this effective treatment for Clostridium difficile (C. difficile) infection and other bowel conditions might soon become mainstream. A recently-reported ...

AGA establishes NIH-funded registry to track fecal microbiota transplants

August 4, 2016
Today, the American Gastroenterological Association (AGA) announced that it has received funding from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to launch ...

Transplanting healthy stool might be an answer to ulcerative colitis

May 23, 2016
Fecal microbiota transplantation (FMT)—a treatment currently used to address recurring Clostridium difficile infection—is also an effective approach to helping individuals who suffer from ulcerative colitis (UC), according ...

New evidence supports success of fecal transplants in treatment of Clostridium difficile infection

April 9, 2015
Research published in the open access journal Microbiome offers new evidence for the success of fecal microbial transplantation (FMT) in treating severe Clostridium difficile infection (CDI), a growing problem worldwide that ...

Article examines fecal microbiota transplantation

August 22, 2013
Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for recurrent Clostridium difficile (C. difficile) infection, with very early experience suggesting that it may also play a role in treating ...

Recommended for you

Screening could catch a quarter of hip fractures before they happen

December 15, 2017
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women - according to new research led by the University of East Anglia (UEA).

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.